These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 7729307)
1. Inferences and implications. Do results from the Diabetes Control and Complications Trial apply in NIDDM? Nathan DM Diabetes Care; 1995 Feb; 18(2):251-7. PubMed ID: 7729307 [No Abstract] [Full Text] [Related]
2. Assessment of glycaemic control in patients with diabetes mellitus on insulin therapy. Mukherjee JJ; Majumdar S; Ray S J Indian Med Assoc; 2013 Nov; 111(11):761-5. PubMed ID: 24968486 [No Abstract] [Full Text] [Related]
10. Using new insulin strategies in the outpatient treatment of diabetes: clinical applications. DeWitt DE; Dugdale DC JAMA; 2003 May; 289(17):2265-9. PubMed ID: 12734138 [TBL] [Abstract][Full Text] [Related]
11. Implications of the Diabetes Control and Complications Trial. American Diabetes Association. Diabetes; 1993 Nov; 42(11):1555-8. PubMed ID: 8405694 [No Abstract] [Full Text] [Related]
12. Should the target A1C level be less than 7 percent? Yes: This should be the target for most patients. Peterson K Am Fam Physician; 2012 Dec; 86(12):1-2. PubMed ID: 23316992 [No Abstract] [Full Text] [Related]
13. Observations on the decay of glycated hemoglobin HbA1c in diabetic patients. Rech ME Exp Clin Endocrinol Diabetes; 1996; 104(2):102-5. PubMed ID: 8740932 [TBL] [Abstract][Full Text] [Related]
14. New Medications for the Treatment of Diabetes. Garg SK; Giordano D Diabetes Technol Ther; 2019 Feb; 21(S1):S160-S171. PubMed ID: 30785325 [No Abstract] [Full Text] [Related]
15. Effect of BMI, insulin dose and number of injections on glycaemic control in insulin-using diabetic patients. Studygroup Diabetes Rijnmond (SDR). Jacobs ML; Elte JW; van Ouwerkerk BM; Janssens EN; Schop C; Knoop JA; Hoogma RP; Groenendijk R; Weber RF Neth J Med; 1997 Apr; 50(4):153-9. PubMed ID: 9130838 [TBL] [Abstract][Full Text] [Related]
16. Intensive glycemic control and cardiovascular disease: an update. Brown A; Reynolds LR; Bruemmer D Nat Rev Cardiol; 2010 Jul; 7(7):369-75. PubMed ID: 20404853 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group. Vignati L; Anderson JH; Iversen PW Clin Ther; 1997; 19(6):1408-21. PubMed ID: 9444449 [TBL] [Abstract][Full Text] [Related]
19. [New fast-acting insulin analog. This insulin profits type l and type 2 diabetics]. Wepner U MMW Fortschr Med; 2004 Nov; 146(47):62-3. PubMed ID: 15624662 [No Abstract] [Full Text] [Related]